85
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Haemo-Adhaesione: A New Measure of Adherence for Adolescent and Adult Patients with Haemophilia

ORCID Icon, ORCID Icon, , , &
Pages 455-465 | Published online: 03 Mar 2020

References

  • Colvin BT, Astermark J, Fischer K, et al. European principles of haemophilia care. Haemophilia. 2008;14(2):361–374. doi:10.1111/hae.2008.14.issue-2
  • Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–e47.
  • Berntorp E, Astermark J, Björkman S, et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia. 2003;9(Suppl 1):1–4. doi:10.1046/j.1365-2516.9.s1.17.x
  • MJ M-J, TC A, AD S, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544. doi:10.1056/NEJMoa067659
  • Valentino LA, Mamonov V, Hellmann A, et al. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost. 2012;10(3):359–367. doi:10.1111/j.1538-7836.2011.04611.x
  • Haynes RB. Compliance in health care. In: Haynes RB, Taylor DW, Sackett DL, editors. . Introduction. Baltimore: Johns Hopkins University Press; 1979.
  • World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2009.
  • De Moerloose P, Urbancik W, Van den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six countries: results and recommendations. Haemophilia. 2008;14:931–938. doi:10.1111/j.1365-2516.2008.01843.x
  • Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia. 2012;18(5):760–765. doi:10.1111/hae.2012.18.issue-5
  • Lock J, Raat H, Duncan N, et al. Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale. Haemophilia. 2014;20:616–623. doi:10.1111/hae.2014.20.issue-5
  • Miesbach W, Kalnins W. Adherence to prophylaxis treatment in patients with haemophilia in Germany. Haemophilia. 2016;22(5):e367–e374. doi:10.1111/hae.13003
  • Schrijvers LH, Beijlevelt‐van der Zande M, Peters M, et al. Adherence to prophylaxis and bleeding outcome in haemophilia: a multicenter study. Br J Haematol. 2016;174:454–460. doi:10.1111/bjh.14072
  • Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia. 2001;7:392–396. doi:10.1046/j.1365-2516.2001.00534.x
  • Llewellyn CD, Miners CD, Lee CA, Harrington C, Weinman J. The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychol Health. 2003;18:185–200. doi:10.1080/0887044031000098198
  • du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia. 2007;13:493–501. doi:10.1111/j.1365-2516.2007.01526.x
  • Duncan N, Kronenberger W, Roberson C, et al. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia. 2010;16:247–255. doi:10.1111/j.1365-2516.2009.02129.x
  • Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-PRN: a new measure of adherence to episodic treatment regimens in haemophilia. Haemophilia. 2010;16(1):47–53. doi:10.1111/hae.2009.16.issue-1
  • Lamiani G, Strada I, Mancusa ME, Coppola A, Vegni E, Moja EA; Pro-adherence study group. Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study. Haemophilia. 2015;21::598–604. doi:10.1111/hae.12654
  • Schrijvers LH, Schuurmans MJ, Fischer K. Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals. Haemophilia. 2016;22:499–506. doi:10.1111/hae.2016.22.issue-4
  • Thornburg CD, Duncan NA. Treatment adherence in hemophilia. Patient Prefer Adherence. 2017;11:1677–1686. doi:10.2147/PPA
  • van Os SB, Troop NA, Sullivan KR, Hart DP. Adherence to prophylaxis in adolescent and young adults with severe haemophilia: a quantitative study with patients. PLoS One. 2017;12(1):e0169880. doi:10.1371/journal.pone.0169880
  • Lamiani G, Bigi S, Mancuso ME, Coppola A, Vegni E. Applying a deliberation model to the analysis of consultations in haemophilia: implications for doctor-patient communication. Patient Educ Couns. 2017;100(4):690–695. doi:10.1016/j.pec.2016.11.021
  • Andrich D. A rating formulation for ordered response categories. Psychometrika. 1978;43:561–573. doi:10.1007/BF02293814
  • Wu ML, Adams RJ, Wilson MR, Haldane SA. AcerConquest v 2.0. ACER; 2007.
  • Lindvall K, Colstrup L, Loogna K, Wollter IM, Grönhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia. 2010;16:592–596. doi:10.1111/j.1365-2516.2009.02189.x
  • Nilson J, Schachter C, Mulder K, et al. A qualitative study identifying the knowledge, attitudes and behaviours of young men with mild haemophilia. Haemophilia. 2012;18:e120–e125. doi:10.1111/hae.2012.18.issue-3
  • Arnold E, Lane S, Weber KE, et al. What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia. Haemophilia. 2014;20:219–225. doi:10.1111/hae.2014.20.issue-2
  • Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia. 2013;19(1):35–43. doi:10.1111/hae.12079
  • Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826–834. doi:10.1097/MLR.0b013e31819a5acc
  • Bigi S. Key components of effective collaborative goal setting in the chronic care encounter. Commun Med. 2014;11(2):103–115. doi:10.1558/cam.v11i2.21600
  • Recht M, Konkle BA, Jackson S, Neufeld EJ, Rockwood K, Pipe S. Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era. Haemophilia. 2016;22:825–832. doi:10.1111/hae.2016.22.issue-6
  • Cuesta-Barriuso R, Torres-Ortuño A, Galindo-Piñana P, Nieto-Munuera J, Duncan N, López-Pina JA. Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia. Patient Prefer Adherence. 2017;11:653–660. doi:10.2147/PPA.S126828